KG-135, a standardized formulation enriched with Rk1, Rg3, Rg5, had been shown to inhibit various types of cancer cells but the underlying mechanisms are not fully understood. We explore its effects in A549 human lung cancer cells to investigate the induction of FOXO3a and autophagy.